Welcome Message
 
Our Company
 
Overview
Diversity
Pledge
History
 
Awards & Recognition
 
Corporate Governance
 
Corporate Compliance
 
Our Websites
 
Business Links
  » BMS.com Home » About Us » Supplier Diversity » About Supplier Diversity
SEARCH INDEX
 


Supplier Diversity



About Supplier Diversity

Our Policy
Bristol-Myers Squibb’s Supplier Diversity is designed to actively pursue opportunities to establish business partnerships with small and diverse businesses.

Through Supplier Diversity, Bristol-Myers Squibb obtains high-quality goods, services and materials from small and diverse businesses. These suppliers share the company’s goal to strive for competitive superiority in all that we do. In addition, Supplier Diversity makes it possible for the company to initiate communication with promising suppliers, today, to start to build relationships for tomorrow.

Bristol-Myers Squibb recognizes that diverse talents and perspectives are vital to achieve success, particularly as the company reaches out to serve the needs of all potential markets and customers. Simply put, working in partnership with small and diverse companies makes good business sense.

Thus, Supplier Diversity’s mission -- to establish partnerships with small and diverse businesses -- is guided not by self-interest, but in the spirit of cooperative efforts, where all partners gain.

Components of Supplier Diversity (PDF)

Small and Diverse Classifications (PDF)

Tier II
In our efforts to strive for continuous improvement in Supplier Diversity, Bristol-Myers Squibb may elect to launch a Tier 2 Program to increase opportunities for certified small and diverse business enterprises in the future. We believe that everyone benefits when all businesses are afforded an opportunity to compete in the market place.




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX